Benjamin Hohl
ELVNBenjamin Hohl serves as officer: CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc. (ELVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Benjamin Hohl's Insider Trading at Enliven Therapeutics, Inc. (ELVN)
Buys
0 · $0.00
Sells
36 · $3.27M
Total Shares Bought
0
Total Shares Sold
144,064
Related Insiders
Helen Louise Collins
officer: CHIEF MEDICAL OFFICER
ELVNSell · Apr 21, 2026
Richard A. Heyman
Director
ELVNSell · Feb 19, 2026
Joseph P Lyssikatos
officer: CHIEF SCIENTIFIC OFFICER
ELVNSell · Feb 10, 2026
Anish Patel
officer: CHIEF OPERATING OFFICER
ELVNSell · Jan 13, 2026
Samuel Kintz
PRESIDENT AND CEO
ELVNSell · Nov 17, 2025